We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Vita Coco Q2 Earnings Beat on Strong Volume, 2026 Guidance Higher
Read MoreHide Full Article
Key Takeaways
Vita Coco beat Q2 estimates as branded demand, pricing and Private Label growth lifted sales and earnings.
COCO raised 2026 sales, margin and adjusted EBITDA guidance following strong quarterly performance.
Copra acquisition and robust international growth strengthen COCO's long-term expansion strategy.
The Vita Coco Company, Inc. (COCO - Free Report) reported second-quarter 2026 earnings of 82 cents per share, up 115.8% year over year. The figure beat the Zacks Consensus Estimate of 56 cents by 46.4%.
Net sales rose 28% to $216 million and surpassed the consensus mark of $212 million. Growth reflected strong branded demand, improved pricing, higher volumes and a 78.1% increase in Private Label.
On July 22, 2026, the company announced that it acquired Copra, Inc., which is among the key producers of super-premium Thai Nam Hom coconut water.
Over the past three months, this Zacks Rank #2 (Buy) company’s shares have gained 34.3%, outpacing the industry’s 2.7% growth.
COCO Sales Gain on Broad-Based Demand
Vita Coco Coconut Water sales increased 21% year over year to $169.7 million. Case-equivalent volume advanced 15%, supported by stronger consumer demand across the company’s major markets and favorable net pricing.
Private Label sales surged 82.8% to $38.2 million. The improvement reflected new and regained distribution, higher retail velocities and particularly strong shipment growth in both operating regions. Other product sales increased 9.6% to $8.2 million.
Vita Coco Company, Inc. Price, Consensus and EPS Surprise
Gross profit jumped nearly 72% year over year to $105.3 million. Gross margin expanded substantially year over year to 48.7%, benefiting from $15.6 million of tariff refunds, improved pricing, lower ocean freight rates and reduced finished-goods costs.
The tariff refunds contributed roughly 700 basis points to the quarterly gross margin. These benefits were partly offset by higher domestic transportation expenses. Management expects current product-cost pressures to weigh on margins during the remainder of the year.
Selling, general and administrative expenses increased 16.7% to $42.2 million. The rise reflected higher incentive compensation, headcount growth, stock-based compensation and additional investments in sales and marketing.
Operating income more than doubled to $63.1 million from $25.1 million. Adjusted EBITDA climbed 129.9% to $67.2 million, as higher gross profit more than offset increased operating investments.
COCO International Growth Outpaces Americas
Americas net sales increased 21.5% to $172.5 million, slightly missing the Zacks Consensus Estimate of $174 million. Vita Coco Coconut Water sales in the region rose 14.5%, while Private Label revenues climbed 83.2%. Branded growth reflected higher volume and pricing.
International sales surged 63% to $43.7 million, outpacing the consensus estimate of $33.8 million. Vita Coco Coconut Water revenues advanced 59.8%, driven by strong volume growth in Europe, particularly in the United Kingdom and Germany. International Private Label sales increased 82.1% on robust demand and favorable pricing.
COCO Ends Quarter With Strong Liquidity
Vita Coco closed the second quarter with $278.6 million in cash and cash equivalents, up from $196.9 million at the end of 2025. The company had no outstanding balance under its $60 million revolving credit facility.
Inventory declined 25.7% year over year to $82.9 million, reflecting strong first-half shipments. Operating cash flow totaled $96.5 million for the first six months of 2026 compared with $12 million in the prior-year period.
The company’s board subsequently approved an additional $40 million authorization, increasing the total share-repurchase program to $105 million.
Vita Coco Raises 2026 Outlook
Management raised its 2026 net sales guidance to $790-$805 million, up from $720-$735 million predicted earlier. The outlook calls for high-teens to 20% growth in Vita Coco Coconut Water sales and continued strength in Private Label shipments.
Gross margin is now expected to be approximately 40%, up from the prior projection of 38%. The revised view reflects tariff refunds, pricing and lower ocean freight costs, partly offset by higher product costs and an unfavorable product mix.
Adjusted EBITDA is projected between $154 million and $161 million, up from the previous range of $132-$138 million. The revised forecast includes the remaining-year contribution from Copra, which Vita Coco acquired in July 2026.
More Stocks to Consider in the Consumer Staples Space
The Zacks Consensus Estimate for United Natural Foods’ current financial-year sales indicates a drop of 2.1% from the prior-year level. UNFI delivered a trailing four-quarter earnings surprise of 29.9%, on average.
Medifast, Inc. (MED - Free Report) , which is a leading manufacturer and distributor of clinically-proven healthy living products and programs, currently carries a Zacks Rank of 2. MED missed the average earnings surprise by a sharp margin in the trailing four quarters.
The Zacks Consensus Estimate for Medifast’s current financial-year sales indicates decline of 25.9% from the year-ago number.
Freshpet, Inc. (FRPT - Free Report) , which manufactures and markets natural fresh foods, refrigerated meals, and treats for dogs and cats, currently carries a Zacks Rank of 2.
The Zacks Consensus Estimate for Freshpet’s current financial-year sales indicates growth of 9.5% from the prior-year level. FRPT delivered a trailing four-quarter earnings surprise of 49.4%, on average.
View the Zacks #1 Rank List
Image: Bigstock
Vita Coco Q2 Earnings Beat on Strong Volume, 2026 Guidance Higher
Key Takeaways
The Vita Coco Company, Inc. (COCO - Free Report) reported second-quarter 2026 earnings of 82 cents per share, up 115.8% year over year. The figure beat the Zacks Consensus Estimate of 56 cents by 46.4%.
Net sales rose 28% to $216 million and surpassed the consensus mark of $212 million. Growth reflected strong branded demand, improved pricing, higher volumes and a 78.1% increase in Private Label.
On July 22, 2026, the company announced that it acquired Copra, Inc., which is among the key producers of super-premium Thai Nam Hom coconut water.
Over the past three months, this Zacks Rank #2 (Buy) company’s shares have gained 34.3%, outpacing the industry’s 2.7% growth.
COCO Sales Gain on Broad-Based Demand
Vita Coco Coconut Water sales increased 21% year over year to $169.7 million. Case-equivalent volume advanced 15%, supported by stronger consumer demand across the company’s major markets and favorable net pricing.
Private Label sales surged 82.8% to $38.2 million. The improvement reflected new and regained distribution, higher retail velocities and particularly strong shipment growth in both operating regions. Other product sales increased 9.6% to $8.2 million.
Vita Coco Company, Inc. Price, Consensus and EPS Surprise
Vita Coco Company, Inc. price-consensus-eps-surprise-chart | Vita Coco Company, Inc. Quote
Vita Coco Margin Expands on Tariff Refunds
Gross profit jumped nearly 72% year over year to $105.3 million. Gross margin expanded substantially year over year to 48.7%, benefiting from $15.6 million of tariff refunds, improved pricing, lower ocean freight rates and reduced finished-goods costs.
The tariff refunds contributed roughly 700 basis points to the quarterly gross margin. These benefits were partly offset by higher domestic transportation expenses. Management expects current product-cost pressures to weigh on margins during the remainder of the year.
Selling, general and administrative expenses increased 16.7% to $42.2 million. The rise reflected higher incentive compensation, headcount growth, stock-based compensation and additional investments in sales and marketing.
Operating income more than doubled to $63.1 million from $25.1 million. Adjusted EBITDA climbed 129.9% to $67.2 million, as higher gross profit more than offset increased operating investments.
COCO International Growth Outpaces Americas
Americas net sales increased 21.5% to $172.5 million, slightly missing the Zacks Consensus Estimate of $174 million. Vita Coco Coconut Water sales in the region rose 14.5%, while Private Label revenues climbed 83.2%. Branded growth reflected higher volume and pricing.
International sales surged 63% to $43.7 million, outpacing the consensus estimate of $33.8 million. Vita Coco Coconut Water revenues advanced 59.8%, driven by strong volume growth in Europe, particularly in the United Kingdom and Germany. International Private Label sales increased 82.1% on robust demand and favorable pricing.
COCO Ends Quarter With Strong Liquidity
Vita Coco closed the second quarter with $278.6 million in cash and cash equivalents, up from $196.9 million at the end of 2025. The company had no outstanding balance under its $60 million revolving credit facility.
Inventory declined 25.7% year over year to $82.9 million, reflecting strong first-half shipments. Operating cash flow totaled $96.5 million for the first six months of 2026 compared with $12 million in the prior-year period.
The company’s board subsequently approved an additional $40 million authorization, increasing the total share-repurchase program to $105 million.
Vita Coco Raises 2026 Outlook
Management raised its 2026 net sales guidance to $790-$805 million, up from $720-$735 million predicted earlier. The outlook calls for high-teens to 20% growth in Vita Coco Coconut Water sales and continued strength in Private Label shipments.
Gross margin is now expected to be approximately 40%, up from the prior projection of 38%. The revised view reflects tariff refunds, pricing and lower ocean freight costs, partly offset by higher product costs and an unfavorable product mix.
Adjusted EBITDA is projected between $154 million and $161 million, up from the previous range of $132-$138 million. The revised forecast includes the remaining-year contribution from Copra, which Vita Coco acquired in July 2026.
More Stocks to Consider in the Consumer Staples Space
United Natural Foods (UNFI - Free Report) , which is the leading distributor of natural, organic and specialty food and non-food products, currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for United Natural Foods’ current financial-year sales indicates a drop of 2.1% from the prior-year level. UNFI delivered a trailing four-quarter earnings surprise of 29.9%, on average.
Medifast, Inc. (MED - Free Report) , which is a leading manufacturer and distributor of clinically-proven healthy living products and programs, currently carries a Zacks Rank of 2. MED missed the average earnings surprise by a sharp margin in the trailing four quarters.
The Zacks Consensus Estimate for Medifast’s current financial-year sales indicates decline of 25.9% from the year-ago number.
Freshpet, Inc. (FRPT - Free Report) , which manufactures and markets natural fresh foods, refrigerated meals, and treats for dogs and cats, currently carries a Zacks Rank of 2.
The Zacks Consensus Estimate for Freshpet’s current financial-year sales indicates growth of 9.5% from the prior-year level. FRPT delivered a trailing four-quarter earnings surprise of 49.4%, on average.